A Spectrum of Views on Clinical Mass Spectrometry
Clin Chem
.
2016 Jan;62(1):30-6.
doi: 10.1373/clinchem.2015.250258.
Epub 2015 Nov 9.
Authors
Thomas Annesley
1
,
Eleftherios Diamandis
2
,
Lorin Bachmann
3
,
Samir Hanash
4
,
Bradley Hart
5
,
Reza Javahery
6
,
Ravinder Singh
7
,
Richard Smith
8
Affiliations
1
Department of Pathology, University of Michigan Health System, Ann Arbor, MI;
[email protected]
.
2
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;
3
Co-Director of Clinical Chemistry, Virginia Commonwealth University Health System, Richmond, VA;
4
Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX;
5
Strategic Director, LSMS Translational Research/IVD/Toxicology, Chromatography and Mass Spectrometry Division, Thermo Fisher Scientific, Waltham, MA;
6
President & CEO, Ionics Mass Spectrometry, Bolton, Ontario, Canada;
7
Director of the Mayo Clinic Endocrine Laboratory, Mayo Clinic, Rochester, MN;
8
Battelle Fellow and Chief Scientist, Environmental Molecular Sciences Laboratory and Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
PMID:
26553793
DOI:
10.1373/clinchem.2015.250258
No abstract available
Publication types
Interview
MeSH terms
Chromatography, Liquid / instrumentation
Clinical Laboratory Techniques* / instrumentation
Humans
Mass Spectrometry* / instrumentation
Point-of-Care Systems